tm logo
KALEIDO
Live/Registered
REGISTERED

on 23 Mar 2021

Last Applicant/ Owned by

65 Hayden Avenue

Lexington

MA

02421

Serial Number

88369612 filed on 03rd Apr 2019

Registration Number

6301922 registered on 23rd Mar 2021

in the Principal Register

Correspondent Address

Christina M. Licursi

WOLF, GREENFIELD & SACKS, P.C.

600 ATLANTIC AVENUE

BOSTON, MA 02210-2206

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

KALEIDO

The mark consists of the word "KALEIDO" to the right of the stylized representation of a round kaleidoscope image. Preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, aRead More

Classification Information


Class [005]
Pharmaceutical Products


Preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis


First Use Date in General

19th Feb 2019

First Use Date in Commerce

08th Jul 2020

Mark Details


Serial Number

No 88369612

Mark Type

No Service/Collective Mark

Attorney Docket Number

No V02792000400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

16.03.05 -

Binoculars, opera glasses, telescopes, microscopes

21.01.25 -

Other games or toys, including darts, jack-in-boxes, rocking horses, paper airplanes, infant toys and toy hoops, arcade games, pinball machines, roulette wheels, video game machines, yoyos

26.01.12 -

Circles with bars, bands and lines

26.01.21 -

Circles that are totally or partially shaded

Description of Design Search

The mark consists of the word "KALEIDO" to the right of the stylized representation of a round kaleidoscope image.

Legal History


Show more

Status DateAction Taken
23rd Mar 2021REGISTERED-PRINCIPAL REGISTER
16th Feb 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15th Feb 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04th Feb 2021STATEMENT OF USE PROCESSING COMPLETE
27th Jan 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
07th Jan 2021USE AMENDMENT FILED
07th Jan 2021TEAS STATEMENT OF USE RECEIVED
09th Jul 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Jul 2020EXTENSION 1 GRANTED
07th Jul 2020TEAS EXTENSION RECEIVED